Ralu Vlad
About Ralu Vlad
Ralu Vlad is the Vice President, Development Team Lead at Bristol-Myers Squibb, with over 20 years of experience in the pharmaceutical industry, focusing on oncology.
Title
Ralu Vlad serves as the Vice President, Development Team Lead at Bristol-Myers Squibb, where she is responsible for overseeing the development team based in Princeton, New Jersey.
Company
Ralu Vlad is currently working at Bristol-Myers Squibb, a leading global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. She has held various significant roles at the company, contributing vastly to its success in oncology.
Experience in Oncology
Ralu Vlad has over 20 years of experience in the pharmaceutical industry with a specific focus on oncology. Throughout her career, she has played a crucial role in advancing oncology treatments. Her work includes leading strategic initiatives and overseeing global regulatory strategies in oncology. Her extensive experience encompasses positions such as Senior Clinical Research Scientist at Novartis and multiple leadership roles at Bristol-Myers Squibb.
Education and Expertise
Ralu Vlad achieved her Doctor of Pharmacy and Bachelor of Science degrees from Rutgers University, completing her studies between 1995 and 2001. She also held a post-doctoral fellowship at Rutgers University Ernest Mario School of Pharmacy, collaborating with Hoffman-La Roche. Her academic background laid a strong foundation for her expertise in the pharmaceutical industry, particularly in oncology.
Professional Background
Ralu Vlad's professional journey includes a variety of influential positions largely focused on oncology. From 2006 to 2021, she progressively advanced at Bristol-Myers Squibb, holding roles such as Associate Director and Director of Medical Strategy – Oncology, Medical Director of Global Medical Affairs – Oncology, Director of US Liaison Global Regulatory Strategy – Oncology, Executive Director of Global Strategic Collaborations, and now as Vice President, Development Team Lead. Her earlier career at Novartis as a Senior Clinical Research Scientist further solidifies her proficiency and leadership in the field.